149 related articles for article (PubMed ID: 6331348)
1. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
Barrett AD; Dimmock NJ
Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
[TBL] [Abstract][Full Text] [Related]
2. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
Barrett AD; Dimmock NJ
J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
[TBL] [Abstract][Full Text] [Related]
4. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
Crouch CF; Mackenzie A; Dimmock NJ
J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
[TBL] [Abstract][Full Text] [Related]
5. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
[TBL] [Abstract][Full Text] [Related]
6. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
Suckling AJ; Jagelman S; Illavia SJ; Webb HE
Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
[TBL] [Abstract][Full Text] [Related]
7. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
Barrett AD; Dimmock NJ
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
[TBL] [Abstract][Full Text] [Related]
8. Variation in homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus.
Barrett AD; Dimmock NJ
J Gen Virol; 1984 Jun; 65 ( Pt 6)():1119-22. PubMed ID: 6726189
[TBL] [Abstract][Full Text] [Related]
9. Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system.
Barrett AD; Cross AJ; Crow TJ; Johnson JA; Guest AR; Dimmock NJ
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1727-32. PubMed ID: 2426395
[TBL] [Abstract][Full Text] [Related]
10. Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity.
Atkins GJ; Sheahan BJ; Dimmock NJ
J Gen Virol; 1985 Mar; 66 ( Pt 3)():395-408. PubMed ID: 2982998
[No Abstract] [Full Text] [Related]
11. Neurogenic spread of Semliki Forest virus in mice.
Kaluza G; Lell G; Reinacher M; Stitz L; Willems WR
Arch Virol; 1987; 93(1-2):97-110. PubMed ID: 2434064
[TBL] [Abstract][Full Text] [Related]
12. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
Dimmock NJ; Kennedy SI
J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
[TBL] [Abstract][Full Text] [Related]
13. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
Fazakerley JK; Webb HE
J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
[TBL] [Abstract][Full Text] [Related]
14. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
Thomson M; White CL; Dimmock NJ
Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
[TBL] [Abstract][Full Text] [Related]
15. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
[TBL] [Abstract][Full Text] [Related]
16. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
Oosterlaken TA; Harmsen M; Kraaijeveld CA; Snippe H
Scand J Immunol; 1990 Feb; 31(2):159-65. PubMed ID: 2155475
[TBL] [Abstract][Full Text] [Related]
17. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
[TBL] [Abstract][Full Text] [Related]
18. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Boere WA; Kraaijeveld CA; Snippe H
Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
[No Abstract] [Full Text] [Related]
19. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
Balcarova J; Helenius A; Simons K
J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
[TBL] [Abstract][Full Text] [Related]
20. Induction of membrane proliferation in mouse CNS by gold sodium thiomalate with reference to increased virulence of the avirulent Semliki Forest virus.
Mehta S; Pathak S; Webb HE
Biosci Rep; 1990 Jun; 10(3):271-9. PubMed ID: 2171692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
